Shanghai Labway Clinical Laboratory Co., Ltd (SHE:301060)
China flag China · Delayed Price · Currency is CNY
10.88
+0.18 (1.68%)
May 19, 2026, 10:35 AM CST

SHE:301060 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
846.05759.5828.95861.2665.81351.96
Trading Asset Securities
-----420.93
Cash & Short-Term Investments
846.05759.5828.95861.2665.81772.89
Cash Growth
5.79%-8.38%-3.74%29.35%-13.85%45.09%
Accounts Receivable
668.15686.13808.631,0332,249819.61
Other Receivables
4.964.9214.546.0811.837.89
Receivables
673.11691.05823.171,0402,261827.5
Inventory
280.92269.81306.09367.71401.52139.44
Prepaid Expenses
---0.118.45-
Other Current Assets
31.931.4540.4357.9751.5627.23
Total Current Assets
1,8321,7521,9992,3273,3891,767
Property, Plant & Equipment
410.33434.04482.58509.74220.96241.11
Long-Term Investments
0.870.981.7614.0616.74-
Goodwill
7.667.667.6615.2417.6430.09
Other Intangible Assets
22.5723.6724.4526.513.0614.81
Long-Term Accounts Receivable
--0.25---
Long-Term Deferred Tax Assets
55.4159.6673.8248.9530.1313.39
Long-Term Deferred Charges
17.8612.6530.0437.1749.632.05
Other Long-Term Assets
1.721.734.128.6710.166.97
Total Assets
2,3482,2922,6232,9873,7472,105
Accounts Payable
447.14402.62388.99502.36858.69253.03
Accrued Expenses
17.8332.5361.9850.07253.6490.24
Short-Term Debt
25.0125.0195.11214.59182.162
Current Portion of Long-Term Debt
33.9537.0415.1415.15--
Current Portion of Leases
--12.0810.7716.8113.67
Current Income Taxes Payable
10.686.7712.549.7351.7628.91
Current Unearned Revenue
8.737.2415.126.628.739.28
Other Current Liabilities
17.919.9514.6413.5522.0315.85
Total Current Liabilities
561.26531.18615.59822.831,414412.98
Long-Term Debt
95.5104133.7145.77--
Long-Term Leases
3.635.3818.2721.0745.6250.03
Long-Term Unearned Revenue
5.826.7110.4211.9414.682.66
Other Long-Term Liabilities
0.120.1225.025.09--
Total Liabilities
666.33647.398031,0071,474465.67
Common Stock
400.52400.52400.52400.52400.52400.52
Additional Paid-In Capital
555.17554.76553.96553.96553.96552.8
Retained Earnings
653.77616.86727.31836.751,109611.62
Treasury Stock
-23.01-23.01-23.01-10.26--
Comprehensive Income & Other
-0.65-0.65-0.65-0.65--
Total Common Equity
1,5861,5481,6581,7802,0631,565
Minority Interest
96.2796.35162.21199.85209.4974.88
Shareholders' Equity
1,6821,6451,8201,9802,2731,640
Total Liabilities & Equity
2,3482,2922,6232,9873,7472,105
Total Debt
158.1171.44274.29407.35244.5965.7
Net Cash (Debt)
687.95588.06554.66453.85421.22707.19
Net Cash Growth
28.03%6.02%22.21%7.75%-40.44%32.75%
Net Cash Per Share
1.781.531.371.121.052.01
Filing Date Shares Outstanding
410.15358.96398.52399.77400.52400.52
Total Common Shares Outstanding
410.15358.96398.52399.77400.52400.52
Working Capital
1,2711,2211,3831,5041,9751,354
Book Value Per Share
3.874.314.164.455.153.91
Tangible Book Value
1,5561,5171,6261,7392,0331,520
Tangible Book Value Per Share
3.794.234.084.355.073.80
Buildings
--337.04333.0258.7728.94
Machinery
--332.87342296.39290.65
Construction In Progress
--0.999.52-16.98
Source: S&P Global Market Intelligence. Standard template. Financial Sources.